Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites
Overview & Synopsis
Follicular lymphoma in situ (FLIS) is composed of a clonal B-cell population harboring the typical t(14;18) hallmark of follicular lymphoma (FL), forming unconventional BCL2 Bright CD10 + cell foci in an otherwise normal reactive lymph node (LN). The diagnosis of FLIS is made on the fortuitous discovery of unconventional BCL2 Bright CD10 + cell foci. 1 Several studies recently demonstrated that FLIS are already advanced precursors in follicular lymphomagene-sis, but not necessarily committed to malignant transformation. 2,3 However, the relationship between FLIS and FL still remains unclear, as only a minority (
Indexed from repository: HAL Open Science
(
hal.science)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | Contiguous follicular lymphoma and follicular lymphoma in situ harboring N-glycosylated sites |
|---|---|
| Author / Organization | Emilie Mamessier, Charlotte Drevet, Florence Broussais-Guillaumot, Marie-Laure Mollichella, Sylvain Garciaz, Sandrine Roulland, Maxime Benchetrit, Bertrand Nadel, Luc Xerri |
| Subject & Discipline | Multidisciplinary Academic Open Research |
| Categories | Science & Mathematics |
| Publication Year | 2015 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
HAL Open Science
(hal.science)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-185862 |
| Original Source Link | Visit Source Page on hal.science » |